Xi T, Rao M R
Department of Cardiovascular Pharmacology, Nanjing Medical College, China.
Zhongguo Yao Li Xue Bao. 1993 Sep;14(5):405-9.
m-Nifedipine (m-Nif 20 mg.kg-1.d-1 ig for 9 wk) decreased left ventricular weight in the renovascular hypertensive rats (P < 0.01). Though not significantly affecting the density of dihydropyridines (DHP) receptor (Bmax), m-Nif administered whether for prevention (6 wk postclipping) or for regression (9 wk postclipping), markedly decreased the total number of DHP binding sites in hypertrophied left ventricle (LV). m-Nif also reduced the dissociation constant (Kd) of DHP binding sites in the membranes of LV and cerebral cortex from cardiac hypertrophied rats (P < 0.01). These effects of m-Nif were similar to those of nifedipine (Nif) in the same dosage. The results suggest that m-Nif can prevent and regress the LV hypertrophy resulted from renovascular hypertension and reduce the total number of DHP binding sites in the membranes of LV from cardiac hypertrophied rats.
间硝苯地平(间硝苯地平20毫克·千克⁻¹·天⁻¹,灌胃给药9周)可降低肾血管性高血压大鼠的左心室重量(P < 0.01)。尽管间硝苯地平对二氢吡啶(DHP)受体的密度(Bmax)无显著影响,但无论是用于预防(夹闭后6周)还是用于逆转(夹闭后9周),间硝苯地平均能显著降低肥厚左心室(LV)中DHP结合位点的总数。间硝苯地平还降低了心脏肥厚大鼠左心室和大脑皮质膜中DHP结合位点的解离常数(Kd)(P < 0.01)。间硝苯地平的这些作用与相同剂量硝苯地平(硝苯地平)的作用相似。结果表明,间硝苯地平可预防和逆转肾血管性高血压所致的左心室肥厚,并减少心脏肥厚大鼠左心室膜中DHP结合位点的总数。